BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15652380)

  • 1. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
    Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
    Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
    Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
    Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory survival mechanisms in acetylcholinesterase knockout mouse.
    Chatonnet F; Boudinot E; Chatonnet A; Taysse L; Daulon S; Champagnat J; Foutz AS
    Eur J Neurosci; 2003 Sep; 18(6):1419-27. PubMed ID: 14511322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
    Minic J; Chatonnet A; Krejci E; Molgó J
    Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of differential expression of acetylcholinesterase in brain and muscle on respiration.
    Boudinot E; Bernard V; Camp S; Taylor P; Champagnat J; Krejci E; Foutz AS
    Respir Physiol Neurobiol; 2009 Jan; 165(1):40-8. PubMed ID: 18977317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
    Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
    J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition.
    Mohr F; Zimmermann M; Klein J
    Neuropharmacology; 2013 Apr; 67():37-45. PubMed ID: 23147415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of huperzine B on cholinesterase activity in mice.
    Liu J; Zhang HY; Wang LM; Tang XC
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.
    Adler M; Manley HA; Purcell AL; Deshpande SS; Hamilton TA; Kan RK; Oyler G; Lockridge O; Duysen EG; Sheridan RE
    Muscle Nerve; 2004 Sep; 30(3):317-27. PubMed ID: 15318343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
    Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
    Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
    Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
    Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.
    Li B; Duysen EG; Poluektova LY; Murrin LC; Lockridge O
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):152-65. PubMed ID: 16443250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
    Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
    Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
    Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
    Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.